{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:07:51Z","timestamp":1790676471472,"version":"4.1.0"},"reference-count":28,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Long COVID is a multi-system syndrome following SARS-CoV-2 infection with persistent symptoms of at least 4 weeks, and frequently for several months. It has been suggested that there may be an autoimmune component. There has been an understandable caution amongst some people experiencing long COVID that, by boosting their immune response, a COVID vaccine may exacerbate their symptoms. We aimed to survey people living with long COVID, evaluating the impact of their first COVID vaccination on their symptoms. Methods: Patients with long COVID were invited to complete a web-based questionnaire through postings on social media and direct mailing from support groups. Basic demographics, range and severity of long COVID symptoms, before and after their vaccine, were surveyed. Results: 900 people participated in the questionnaire, of whom 45 had pre-existing myalgic encephalomyelitis or chronic fatigue syndrome (ME\/CFS) but no evidence of COVID infection, and a further 43 did not complete the survey in full. The demographics and symptomology of the remaining 812 people were similar to those recorded by the UK Office of National Statistics. Following vaccination, 57.9% of participants reported improvements in symptoms, 17.9% reported deterioration and the remainder no change. There was considerable individual variation in responses. Larger improvements in symptom severity scores were seen in those receiving the mRNA vaccines compared to adenoviral vector vaccines. Conclusions: Our survey suggests COVID-19 vaccination may improve long COVID patients, on average. The observational nature of the survey limits drawing direct causal inference, but requires validation with a randomised controlled trial.<\/jats:p>","DOI":"10.3390\/vaccines10050652","type":"journal-article","created":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T02:22:02Z","timestamp":1650766922000},"page":"652","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6826-418X","authenticated-orcid":false,"given":"William David","family":"Strain","sequence":"first","affiliation":[{"name":"Diabetes and Vascular Research Centre, University of Exeter Medical School, Barrack Road, Exeter EX2 5AX, UK"},{"name":"Academic Department of Healthcare for Older People, Royal Devon & Exeter Hospital Barrack Road, Exeter EX2 5DW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4421-2382","authenticated-orcid":false,"given":"Ondine","family":"Sherwood","sequence":"additional","affiliation":[{"name":"LongCovidSOS, Patient Advocacy Group, Surrey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London Hospitals NHS Trust, London NW1 2DA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Van der Togt","sequence":"additional","affiliation":[{"name":"Research-Aid Networks, Chicago, IL 60605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyth","family":"Hishmeh","sequence":"additional","affiliation":[{"name":"LongCovidSOS, Patient Advocacy Group, Surrey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-4103","authenticated-orcid":false,"given":"Jeremy","family":"Rossman","sequence":"additional","affiliation":[{"name":"Research-Aid Networks, Chicago, IL 60605, USA"},{"name":"School of Biosciences, University of Kent, Kent CT2 7NJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.7861\/clinmed.2020-0204","article-title":"Long-term sequelae following previous coronavirus epidemics","volume":"21","year":"2021","journal-title":"Clin. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1473-3099(16)30516-3","article-title":"Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): An observational cohort study","volume":"17","author":"Etard","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tmaid.2017.01.004","article-title":"Long-term sequelae of chikungunya virus disease: A systematic review","volume":"15","author":"Nelen","year":"2017","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Worldometer (2022, March 23). COVID-19 Coronavirus Pandemic. Available online: https:\/\/www.worldometers.info\/coronavirus\/.","DOI":"10.4324\/9781003345091-3"},{"key":"ref_5","unstructured":"Ayoubkhani, D., and Munro, M. (2022, March 23). Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK, Available online: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk\/3march2022."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: A cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s11606-020-06338-4","article-title":"Post-Discharge Health Status and Symptoms in Patients with Severe COVID-19","volume":"36","author":"Weerahandi","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-021-01433-3","article-title":"Long COVID in a prospective cohort of home-isolated patients","volume":"27","author":"Blomberg","year":"2021","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113426","DOI":"10.1016\/j.socscimed.2020.113426","article-title":"How and why patients made Long Covid","volume":"268","author":"Callard","year":"2021","journal-title":"Soc. Sci. Med."},{"key":"ref_10","unstructured":"NICE (2021, December 13). COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19 NICE Guideline [NG188], Available online: https:\/\/www.nice.org.uk\/guidance\/ng188."},{"key":"ref_11","unstructured":"World Health Organisation (2021, December 13). A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/345824\/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e913","DOI":"10.1097\/PR9.0000000000000913","article-title":"Patient-Led Research Collaborative: Embedding patients in the Long COVID narrative","volume":"6","author":"McCorkell","year":"2021","journal-title":"Pain Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19: A systematic review and meta-analysis","volume":"11","author":"Perelman","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ladds, E., Rushforth, A., Wieringa, S., Taylor, S., Rayner, C., Husain, L., and Greenhalgh, T. (2020). Persistent symptoms after Covid-19: Qualitative study of 114 \"long Covid\" patients and draft quality principles for services. BMC Health Serv. Res., 20.","DOI":"10.1186\/s12913-020-06001-y"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"n132","DOI":"10.1136\/bmj.n132","article-title":"Decoding the unknowns in long covid","volume":"372","author":"Altmann","year":"2021","journal-title":"BMJ"},{"key":"ref_17","unstructured":"(2020). Meeting the challenge of long COVID. Nat. Med., 26, 1803. Available online: https:\/\/www.nature.com\/articles\/s41591-020-01177-6."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e048391","DOI":"10.1136\/bmjopen-2020-048391","article-title":"Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study","volume":"11","author":"Dennis","year":"2021","journal-title":"BMJ Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e14726","DOI":"10.14814\/phy2.14726","article-title":"SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation","volume":"9","author":"Ostergaard","year":"2021","journal-title":"Physiol. Rep."},{"key":"ref_20","unstructured":"Medical Research Council (2021, March 15). Do I Need NHS REC Review?, Available online: http:\/\/www.hra-decisiontools.org.uk\/ethics\/engset1.html."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7326\/0003-4819-100-1-122","article-title":"Multiple testing of hypotheses in comparing two groups","volume":"100","author":"Cupples","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Arnold, D.T., Milne, A., Samms, E., Stadon, L., Maskell, N.A., and Hamilton, F.W. (2021). Are vaccines safe in patients with Long COVID? A prospective observational study. medRxiv.","DOI":"10.1101\/2021.03.11.21253225"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Taquet, M., Dercon, Q., Luciano, S., Geddes, J.R., Husain, M., and Harrison, P.J. (2021). Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med., 18.","DOI":"10.1371\/journal.pmed.1003773"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2213-2600(22)00020-0","article-title":"Do vaccines protect from long COVID?","volume":"10","author":"Venkatesan","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_26","unstructured":"UK Health Security Agency (2021, December 13). The Effectiveness of Vaccination against Long COVID: A Rapid Evidence Briefing, Available online: https:\/\/ukhsa.koha-ptfs.co.uk\/cgi-bin\/koha\/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41420-021-00464-6","article-title":"Long COVID: An estrogen-associated autoimmune disease?","volume":"7","author":"Ortona","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/5\/652\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:57:59Z","timestamp":1760137079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/5\/652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["vaccines10050652"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10050652","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]}}}